CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
intracavitary balloon brachytherapy +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00945061
NCT00945061N/ACompleted

Partial Breast Re-Irradiation for Patients With Ipsilateral Breast Tumor Recurrence, After First Being Treated With Breast Conservation for Early Stage Breast Cancer: An Efficacy Trial Comparing Mammosite® and Intraoperative Radiation

Case Comprehensive Cancer Center·interventional·Posted Jul 23, 2009·Updated Aug 18, 2020

In Brief

A clinical study evaluating intracavitary balloon brachytherapy and intraoperative radiation therapy for Breast Cancer. Completed, enrolled 13 participants across 3 sites.

Detailed Summary

RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. It is not yet known whether a single dose of radiation therapy is more effective than implant radiation therapy for 5 days in treating patients with recurrent breast cancer. PURPOSE: This phase II trial is studying implant radiation therapy to see how well it works compared with radiation therapy during surgery in treating patients with recurrent breast cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 23, 2009
Enrollment StartSep 23, 2008
Primary CompletionJul 6, 2018
TodayJul 2, 2026
Enrollment to primary: 9.8 yearsPosted 16.9 years ago

Interventions

intracavitary balloon brachytherapyradiation

Patients undergo brachytherapy

intraoperative radiation therapyradiation

Patients undergo radiotherapy